Raymond James Trust N.A. Eli Lilly & CO Transaction History

Raymond James Trust N.A.

$4.22 Billion
Q2 2024

A detailed history of Raymond James Trust N.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Raymond James Trust N.A. holds 34,703 shares of LLY stock, worth $31.3 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

34,703

Previous 32,964 5.28%

Holding current value

$31.3 Million

Previous $25.6 Million 22.52%

% of portfolio

0.74%

Previous 0.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $1.26 Million - $1.58 Million	1,739 Added 5.28%	34,703 $31.4 Million
Q1 2024 Apr 24, 2024	BUY	$592.2 - $792.28 $259,383 - $347,018	438 Added 1.35%	32,964 $25.6 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $269,947 - $318,232	514 Added 1.61%	32,526 $19 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $972,858 - $1.34 Million	2,238 Added 7.52%	32,012 $17.2 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $1.81 Million - $2.42 Million	-5,164 Reduced 14.78%	29,774 $14 Million
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $1.3 Million - $1.52 Million	4,172 Added 13.56%	34,938 $12 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $210,615 - $245,408	-655 Reduced 2.08%	30,766 $11.3 Million
Q3 2022 Oct 31, 2022	BUY	$296.48 - $337.87 $52,476 - $59,802	177 Added 0.57%	31,421 $10.2 Million
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $264,236 - $310,251	-948 Reduced 2.94%	31,244 $10.1 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $57,029 - $70,873	-243 Reduced 0.75%	32,192 $9.22 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $1.13 Million - $1.4 Million	-5,026 Reduced 13.42%	32,435 $8.96 Million
Q3 2021 Oct 18, 2021	SELL	$221.6 - $272.71 $1.26 Million - $1.54 Million	-5,664 Reduced 13.13%	37,461 $8.66 Million
Q2 2021 Jul 20, 2021	BUY	$180.55 - $233.54 $62,109 - $80,337	344 Added 0.8%	43,125 $9.9 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $734,510 - $950,858	-4,470 Reduced 9.46%	42,781 $7.99 Million
Q4 2020 Jan 13, 2021	SELL	$130.46 - $172.63 $255,179 - $337,664	-1,956 Reduced 3.98%	47,251 $7.98 Million
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $6,872 - $7,949	-47 Reduced 0.1%	49,207 $7.28 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $27,829 - $33,492	-204 Reduced 0.41%	49,254 $8.09 Million
Q1 2020 Apr 17, 2020	BUY	$119.05 - $147.35 $473,938 - $586,600	3,981 Added 8.75%	49,458 $6.86 Million
Q4 2019 Jan 14, 2020	SELL	$106.92 - $132.43 $359,785 - $445,626	-3,365 Reduced 6.89%	45,477 $5.98 Million
Q3 2019 Oct 24, 2019	BUY	$106.79 - $116.16 $822,710 - $894,896	7,704 Added 18.73%	48,842 $5.46 Million
Q2 2019 Jul 15, 2019	BUY	$110.79 - $129.32 $61,488 - $71,772	555 Added 1.37%	41,138 $4.56 Million
Q1 2019 Apr 15, 2019	BUY	$111.31 - $131.02 $64,782 - $76,253	582 Added 1.45%	40,583 $5.27 Million
Q4 2018 Jan 29, 2019	SELL	$105.9 - $118.64 $93,933 - $105,233	-887 Reduced 2.17%	40,001 $4.63 Million
Q3 2018 Oct 16, 2018	BUY	$85.86 - $107.31 $7,212 - $9,014	84 Added 0.21%	40,888 $4.39 Million
Q2 2018 Jul 11, 2018	BUY	$75.7 - $86.88 $39,893 - $45,785	527 Added 1.31%	40,804 $3.48 Million
Q1 2018 Apr 05, 2018	SELL	$74.21 - $87.6 $31,242 - $36,879	-421 Reduced 1.03%	40,277 $3.12 Million
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $260,978 - $279,929	-3,185 Reduced 7.26%	40,698 $3.44 Million
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $19,190 - $21,299	249 Added 0.57%	43,883 $3.75 Million
Q2 2017 Aug 10, 2017	BUY	N/A	43,634	43,634 $3.59 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Account

Raymond James Trust N.A. Eli Lilly & CO Transaction History